3 major benefits of short-acting oral contraceptives

Editor's recommendation: Should women be conservative or unrestrained in bed?

　　Benefit 1: Relieve premenstrual tension syndrome

　　In addition to being effective in contraception, short-acting oral contraceptives can also help women regulate their menstrual cycles, relieve premenstrual tension syndrome, and reduce breast size. distended pain , mood swings, headaches, etc. In addition, it can also be used to treat Acne ,make skin More polished. In addition, short-acting oral contraceptives can also delay women’s menopause When the period comes, protect cardiovascular function and delay the aging of the body.

　　Benefit 2: Effective weight control

　　Many women worry about gaining weight while taking short-acting oral contraceptives. Traditional short-acting oral contraceptives do cause women to gain weight due to water and sodium retention. However, there are already clinical Evidence shows that newer short-acting oral contraceptives are effective in controlling weight. Because the drospirenone component contained in it has anti-mineralocorticoid properties similar to natural progesterone, it can directly combat water and sodium retention and promote water and sodium excretion.

　　Benefit 3: Reduce the incidence of related tumors

　　Contrary to common misunderstandings among Chinese women, taking new short-acting oral contraceptives will not increase the risk of female reproductive system tumors and breast cancer risk and even reduce the incidence of related tumors. Hannaford et al. on oral contraceptives and cancer The study looked at 744,000 people who had ever or currently used oral contraceptives and 339,000 people who did not use oral contraceptives. The results showed that oral contraceptive users had a significant 12% lower overall cancer incidence rate than non-users.

　　reduce Uterus Risk of endometrial cancer: A large number of clinical studies have shown that short-acting oral contraceptives can significantly reduce the risk of endometrial cancer. This is because low-dose estrogen can prevent excessive proliferation of the endometrium, thereby reducing the chance of malignant transformation. Foreign studies have shown that the new generation of short-acting oral contraceptives can still protect the endometrium one to two years after stopping the drug.

　　confrontation ovarian cancer : The most authoritative evidence-based medical evidence to date on short-acting oral contraceptives in preventing ovarian cancer, published in The Lancet in 2008, shows: ① Taking short-acting oral contraceptives has a long-term preventive effect on ovarian cancer.； ②The longer you take it, the lower your risk of ovarian cancer ； ③The protective effect persisted 30 years after the drug was discontinued.

　　It has little to do with the prevalence of breast cancer: in fact, the incidence of breast cancer is more closely related to factors such as race, genetics, smoking, and age. A large number of surveys conducted in the United Kingdom, the United States and Canada after 2002 have shown that women who have long-term use or current use of conventional short-acting oral contraceptives have no significant increase in the risk of breast cancer.

    Great reading: 21 secrets in bed that women don’t understand  Six signs suggesting kidney deficiency in women